期刊文献+

肝素衍生物结构与抑制高糖引起人系膜细胞增殖的关系研究 被引量:2

Structure-activity relationship of heparin derivatives structures and their antiproliferation activity on high glucose-induced mesangial cell proliferation
下载PDF
导出
摘要 目的考察肝素结构与抑制高糖引起人肾小球系膜细胞增殖活性之间的关系。方法采用化学修饰的方法制备2,3-O-脱硫酸肝素、6-O-脱硫酸肝素、N-脱硫酸肝素、高碘酸氧化/硼氢化钠还原肝素、羧基还原肝素和多硫酸化肝素,通过比浊法测得硫酸基团含量,核磁图谱分析肝素修饰物;MTT法比较这些肝素修饰物对高糖引起人肾小球系膜细胞增殖的抑制活性。结果多硫酸化肝素抑制活性显著增加,羧基还原肝素、高碘酸氧化/硼氢化钠还原肝素抑制活性相对肝素没有明显改变,而2,3-O-脱硫酸肝素、6-O-脱硫酸肝素和N-脱硫酸化肝素抑制活性显著降低。结论抑制活性大小的顺序和硫酸基团含量大小顺序一致,说明肝素中硫酸基团的含量是影响肝素抑制高糖引起人肾小球系膜细胞增殖的主要因素。 Purpose To investigate the relationship between the structure of heparin derivatives and antiproliferative activity on high glucose-induced mesangial cell proliferation. Methods Preparation of 2, 3-O- desulfated hcparin, 6- O-desulfated heparin, N-desulfated heparin, periodate-oxidized/borohydride-reduced heparin, carboxyl-reduced heparin and poly-sulfated heparin by chemical method. Sulfate content (SO4^2- , % ) was determined by turbidimetrical asbarium sulfate and the structure of chemically modified heparin was verified by NMR spectroscopy. The anti-proliferative activities were assayed by MTT. Results Compared to heparin, the anti-proliferative activity of poly-sulfated heparin was significantly increased and the activity of periodate-oxidized/borohydride-reduced heparin and carboxyl-reduced heparin had no obvious change, while the 2,3- O-desulfated,6- O-desulfated and N-desulfated heparin was significantly decreased. Conclusion The order of anti-proliferative activities of chemically modified heparin is consistent with the content of SO4^2- . These results indicated that the content of SO4^2- is the major factor of heparin's structure for the inhibitive effect on high glucose-induced mesangial cell proliferation.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2009年第5期294-297,共4页 Chinese Journal of Biochemical Pharmaceutics
基金 安徽省高等学校自然科学基金项目(KJ2009B148)
关键词 肝素衍生物 结构 高糖 人肾小球系膜细胞 增殖 heparin derivatives structure high glucose human mesangial cell proliferation
  • 相关文献

参考文献13

  • 1Gross J L, de Azevedo M J, Silveiro S P, et al. Diabetic nephropathy: diagnosis, prevention, and treatment[ J]. Kidney Int, 2005,28 ( 1 ) : 164- 176.
  • 2Andrea C S, Bruce M H. The regulation of mesangial cell proliferation [J]. Nephron Exp Nephrol,2008,108(4) :74-79.
  • 3孙滨,杨明.低分子肝素钠在治疗早期糖尿病肾病临床疗效评价[J].实用医技杂志,2007,14(20):2764-2765. 被引量:1
  • 4Marshall S M, Hansen K W, Osterby R, et al. Effects of heparin on renal morphology and albuminuria in experimental diabetes [ J ]. Am J Physiol, 1996,271 (2 Pt 1 ) : E326-E332.
  • 5ZHOU Qiao-ling Yasumoto Yuichiro Tsukamoto Masatoshi Nozaki Tsuyoshi Sogabe Atsushi Harada Kouji ZHANG Yi-xiang LIN Xiao-yan ZHANG Yang-de Arima Terukatsu.Effect of heparin on high glucose induced proliferation and expression of matrix metalloproteinases in normal human mesangial cells[J].Journal of Central South University of Technology,2005,12(z1):359-364. 被引量:3
  • 6Jaseja M, Rej R N, Sauriol F. Novel rejio- and stereoselective modifications of heparin in alkaline solution, nuclear magnetic resonanece spectroscopic evidence[ J]. Can J Chem, 1989,67(9) : 1449-1456.
  • 7Wang J G, Mu J S. N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo [ J ]. Inflamm Res, 2002,51(9) :435-443.
  • 8Kariya Y, Kyogashima M, Suzuki K, et al. Preparation of completely 6- O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor[J] .J Bio Chem,2000,275(34):25949-25958.
  • 9Seigo U, Yutaka K, Harald R, et al. Enhancement of neufite outgrowthpromoting activity by heparin derivatives in sodium chlorate-treated explant cultures of rat central neurons[ J]. J Biochem, 2003,133 (6) :783- 790.
  • 10Wessel H P, Hosang M, Tschopp T B, et al. Heparin, carboxyl-reduced sulfated heparin, and trestatin A sulfate. Antiproliferative and anticoagulant activities[J]. Carbohydr Res, 1990,204(9) : 131-139.

二级参考文献35

  • 1崔慧斐 姬胜利 王凤山 等.高度硫酸化的低分子肝素的制备及其降血脂作用研究[A]..2000年中国药学会学术年会论文集(下册)[C].北京:中国药学会,2000.905-906.
  • 2[19]Striker L J.Peten E P,Elliot S J,et al.Mesangial cell turnerover effect of heparin and peptide growth factor[J].Lab Invest,1991,64:446-456.
  • 3[20]Castellot J J,Hoover R L,Harper P A,et al.Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial cell proliferation[J].Am J Pathol,1985,120:427-435.
  • 4[21]Castellot J J,Hoover R L,Karnovsky M J.Glomerular endothelial cells secrete a heparin-like inhibitor and a peptide stimulator of mesangial cell proliferation[J].Am J Pathol,1986,125:493-500.
  • 5[22]Groggel G C,Marinidez G N,Hovingh P,et al.Inhibition of rat mesangial cell growth by heparin sulfate[J].Am J Physiol,1990,258:F259-265.
  • 6[23]Kreisberg J I,Kreisberg S H.High glucose activates PKC and stimulates fibronectin gene expression by enhancing a cAMP response element[J].Kidney Iht,1995,48(S 51):S3-Sll.
  • 7[24]Yokoyama H,Deckert T.Central role of TGF-β in the pathogenesis of diabetic nephropathy and macro vascular complications[J].Diabet Med,1996,13:313-320
  • 8[25]Studer R K,Craven P A,Derbrtis F R.Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high glucose medium[J].AmJ Pathol,1989,134:843-855.
  • 9[26]Handa M,Araki S,Togawa M,et al.Mitogen-activated-protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions[J].Diabetes,1997,46:847-853.
  • 10[27]Crowley S T,Brownlee M,Edelstein D,et al.Effects of no nenzymatic glycosylation of matrix on proliferation of mesangial cells[J].Diabetes,1991,40:540-547.

共引文献8

同被引文献49

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部